Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001409583 | SCV001611613 | likely benign | Neurofibromatosis, type 1 | 2018-10-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003169362 | SCV003890947 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2023-02-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |